 |
인쇄하기
취소
|
Dong-A Pharm acquires Samchully Pharm for 50 billion won
Dong-A Pharmaceutical Co., the top Korean drug maker, said on May 4 that it has struck a deal to take over Samchully Pharm for 50 billion won in its first acquisition of a domestic company.
“It will help us make inroads into the growing pharmaceutical raw material market in the global arena.
Founded in 1983, Samchully is one of the biggest manufacturers of nucleoside active pharmaceutical...
“It will help us make inroads into the growing pharmaceutical raw material market in the global arena.
Founded in 1983, Samchully is one of the biggest manufacturers of nucleoside active pharmaceutical...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.